Sit Investment Associates Inc. grew its position in shares of CME Group Inc (NASDAQ:CME) by 31.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 87,025 shares of the financial services provider’s stock after acquiring an additional 20,795 shares during the quarter. Sit Investment Associates Inc.’s holdings in CME Group were worth $12,710,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Federated Investors Inc. PA increased its stake in CME Group by 28.1% in the 2nd quarter. Federated Investors Inc. PA now owns 7,456 shares of the financial services provider’s stock worth $934,000 after buying an additional 1,636 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its stake in CME Group by 11.2% in the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 14,116 shares of the financial services provider’s stock worth $1,768,000 after buying an additional 1,420 shares in the last quarter. Fiduciary Trust Co. purchased a new stake in CME Group in the 2nd quarter worth $105,000. Old Mutual Global Investors UK Ltd. purchased a new stake in CME Group in the 2nd quarter worth $162,000. Finally, Engineers Gate Manager LP purchased a new stake in CME Group in the 2nd quarter worth $755,000. 82.70% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Inc (NASDAQ:CME) opened at $152.90 on Thursday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group Inc has a 1-year low of $113.90 and a 1-year high of $155.29. The company has a market cap of $52,030.00, a PE ratio of 34.67, a P/E/G ratio of 2.55 and a beta of 0.72.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.05 earnings per share. research analysts expect that CME Group Inc will post 4.76 earnings per share for the current year.

The company also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th will be paid a $3.50 dividend. The ex-dividend date of this dividend is Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio (DPR) is presently 59.86%.

In other news, Director Jeffrey M. Bernacchi sold 1,501 shares of CME Group stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $149.75, for a total transaction of $224,774.75. Following the completion of the sale, the director now owns 60,194 shares of the company’s stock, valued at $9,014,051.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 5,175 shares of CME Group stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The disclosure for this sale can be found here. In the last three months, insiders sold 42,603 shares of company stock valued at $6,250,726. 0.57% of the stock is owned by insiders.

A number of brokerages have issued reports on CME. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a research report on Tuesday, January 2nd. Barclays raised their price objective on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. Wells Fargo & Co raised their price objective on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. Finally, Royal Bank of Canada raised their price objective on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and a consensus target price of $144.22.

ILLEGAL ACTIVITY NOTICE: This article was originally published by Watch List News and is the property of of Watch List News. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/cme-group-inc-cme-shares-bought-by-sit-investment-associates-inc/1802598.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.